Johnson & Johnson

Symbol: JNJ

NYSE

149.92

USD

Market price today

  • 8.9789

    P/E Ratio

  • -0.0975

    PEG Ratio

  • 361.27B

    MRK Cap

  • 0.03%

    DIV Yield

Johnson & Johnson (JNJ) Stock Split, History Data

Working capital analysis

In terms of working capital, Johnson & Johnson maintains a healthy position. The total current assets of the company are valued at $55294000000. This represents a growth rate of -9.323% compared to the previous year. Breaking down the current assets, the cash and investments are worth $14127000000, exhibiting a growth rate of -2.485% year-on-year. The receivables, another significant portion of the current assets, are valued at $16160000000. The year-on-year growth rate for receivables is 5.738%. The inventory, which forms a critical part of the assets, is valued at $12483000000. This represents a healthy year-on-year growth of 20.179% On the liabilities side, the company's current liabilities total $55802000000. This reflects a growth rate of 23.385% over the previous year, indicating the company's financial obligations are well under control.

202320222021201920182017
Cash and investments
14127.00
14487.00
13985.00
17305.00
18107.00
18972.00
Receavebles
16160.00
15283.00
13576.00
14481.00
14098.00
11699.00
Inventory
12483.00
10387.00
9344.00
9020.00
8599.00
8144.00
Other
3132.00
3701.00
3132.00
2486.00
3649.00
3282.00
Total Current Assets
55294.00
60979.00
51237.00
45274.00
46033.00
65032.00
Acc Payable
11703.00
11055.00
9505.00
8544.00
7537.00
6918.00
Short Term Debt
12771.00
3766.00
2631.00
1202.00
2796.00
4684.00
Other Current Liab
31328.00
30405.00
30357.00
26218.00
13257.00
8537.00
Current Liabilities
55802.00
45226.00
42493.00
35964.00
31230.00
26287.00

Capital Structure

When examining the capital structure of Johnson & Johnson, it is clear that the company manages a robust portfolio. The value of their total assets clocks in at $171966000000. When juxtaposed with the previous year, this marks a growth rate of -12.248%, showcasing the company's ability to steadily grow its asset base. Turning to liabilities, the company has total liabilities amounting to $101946000000. Compared to the prior year, this reflects a growth rate of -18.508%. The long-term debt forms a sizable part of these liabilities, coming in at $25082000000. Over the last year, the long-term debt has grown by -28.189%. On the asset side, the cash and equivalent reserves are worth $-22927000000. The year-on-year growth of these reserves is -185.342%. The company's common stock, another important asset, holds a value of $3120000000, growing at a rate of 0.000% from the previous year. Finally, the company's retained earnings stand at $153378000000, marking a growth rate of 23.138% year-over-year. These earnings represent the profits that Johnson & Johnson has chosen to reinvest in the business rather than distribute as dividends.

Total Assets

$171,966.00

Total liabilities

$101,946,000,000.00

Long term debt

$25,082.00

Cash and eqv

-$22,927,000,000.00

Goodwill

$36,616.00

Retained earnings

$153,378,000,000.00

Common stock

$0.00

Enterprise Value

$9.97

Historical dividend key summary

Johnson & Johnson's dividend per share is $4.76, showing the earnings shared with shareholders per share. It has grown by -48.298% this year, suggesting that the company is generating increased income for shareholders and expecting future earnings growth.

YearsQ1Q2Q3Q4Total
20241.1901.2400.0000.0002.430
20231.1301.1901.1901.1904.700
20221.0601.1301.1301.1304.450
20211.0101.0601.0601.0604.190
20200.9501.0101.0101.0103.980
20190.9000.9500.9500.9503.750
20180.8400.9000.9000.9003.540
20170.8000.8400.8400.8403.320
20160.7500.8000.8000.8003.150
20150.7000.7500.7500.7502.950
20140.6600.7000.7000.7002.760
20130.6100.6600.6600.6602.590
20120.5700.6100.6100.6102.400
20110.5400.5700.5700.5702.250
20100.4900.5400.5400.5402.110
20090.4600.4900.4900.4901.930
20080.4150.4600.4600.4601.795
20070.3750.4150.4150.4151.620
20060.3300.3750.3750.3751.455
20050.2850.3300.3300.3301.275
20040.2400.2850.2850.2851.095
20030.2050.2400.2400.2400.925
20020.1800.2050.2050.2050.795
20010.1600.1800.1800.1800.700
20000.1400.1600.1600.1600.620
19990.1250.1400.1400.1400.545
19980.1100.1250.1250.1250.485
19970.0950.1100.1100.1100.425
19960.0830.0950.0950.0950.367
19950.0720.0830.0830.0830.320
19940.0650.0720.0720.0720.282
19930.0580.0650.0650.0650.253
19920.0500.0580.0580.0580.223
19910.0430.0500.0500.0500.193
19900.0360.0430.0430.0430.164
19890.0310.0360.0360.0360.140
19880.0260.0310.0310.0310.120
19870.0220.0260.0260.0260.101
19860.0200.0220.0220.0220.086
19850.0190.0200.0200.0200.080
19840.0170.0190.0190.0190.073
19830.0160.0170.0170.0170.067
19820.0140.0160.0160.0160.061
19810.0120.0140.0140.0140.053
19800.0100.0120.0120.0120.046
19790.0100.0100.0100.0100.042
19780.0090.0090.0090.0090.035
19770.0070.0070.0070.0070.029
19760.0060.0050.0050.0050.022
19750.0050.0040.0040.0040.018
19740.0040.0030.0040.0040.015
19730.0030.0030.0030.0030.011
19720.0030.0020.0020.0020.009
19710.0030.0020.0020.0020.009
19700.0020.0020.0020.0020.007

Net earnings per share (EPS)

Johnson & Johnson has an EPS of $2.20, which signifies the profit allocated per share of common stock. With a growth rate of -84.391% this year, it indicates the company's increasing profitability and potential for share value growth. This trend signals robust financial performance and future potential.

YearsQ1Q2Q3Q4Total
20242.2---2.20
2023-0.02581.9610.811.3514.06
20221.961.831.71.87.29
20212.352.381.390.666.78
20202.21.381.35-4.93
20191.412.121.841.526.89
20181.631.471.471.125.69
20171.631.421.41.41.86
20161.561.451.561.165.73
20151.561.631.21-4.40
20141.671.531.690.915.80
20131.251.361.061.254.92
20121.420.511.070.08134.00
20111.271.011.170.74.15
20101.641.251.240.794.92
20091.271.151.2-3.62
20081.271.181.190.974.61
20070.891.060.880.823.65
20061.10.960.950.694.45
20050.960.870.850.43.08
20040.840.830.79-2.46
20030.70.410.70.622.43
20020.60.550.580.462.19
20010.510.490.50.361.86
20000.480.460.440.251.95
19990.410.420.40.01491.24
19980.380.380.36-1.12
19970.340.340.320.191.19
19960.30.30.280.211.09
19950.260.260.240.141.07
19940.220.220.210.130.78
19930.20.190.18-0.57
19920.180.180.17-0.130.40
19910.160.160.140.10.56
19900.0950.140.120.0890.44
19890.120.120.10.0790.42
19880.110.10.090.0650.37
19870.0850.0850.080.060.32
1986-0.050.0650.0650.0350.12
1985--0.0550.040.10

Johnson & Johnson (JNJ) stock split history

Understanding the historical stock splits of Johnson & Johnson (JNJ) provides insights into its past financial decisions and investor sentiment. A stock split occurs when a company increases its share count by dividing its existing shares. The most recent split took place on June 13, 2001 with a ratio of 2:1. Throughout its history, the company has undergone 7 stock splits. Below, we delve deeper into this history, highlighting past financial strategies.

DateSplit Ratio
13 June 20012:1
12 June 19962:1
10 June 19922:1
11 May 19892:1
19 May 19813:1
18 May 19703:1
19 June 19673:1

Frequently Asked Question

What is the latest historical split date of the company?

The latest historical split date is N/A.

What is firm free cah flow per share (FCF per share)?

The free cah flow per share (FCF per share) is 7.697.

What is company revenue per share?

The company revenue per share is 0.258.

What are firm earnings per share?

The firm earnings per share is 1.746.

What is Johnson & Johnson (JNJ) ROIC (return on capital)?

Johnson & Johnson (JNJ) ROIC (return on capital) is 0.187.

What is dividend per share figure?

The dividend per share is 4.760

What is enterprise plowback ratio?

Johnson & Johnson (JNJ) plowback ratio is N/A

What is firm enterprise value (EV)?

The enterprise value (EV) is 9.972

What is company debt to equity ratio?

The debt to equity ratio is 0.489

What are debt ratio numbers?

The debt ratio is 0.196

What is company price to sales ratio?

The price to sales ratio is 4.029